RSS   Newsletter   Contact   Advertise with us
Post Online Media

Biocept appoints Michael Terry SVP, commercial operations

BioceptBiocept, Inc., a molecular diagnostics company, announces the appointment of Michael Terry to the newly created position of senior vice president commercial operations.
Most recently, Mr. Terry was Executive Vice President, Commercial Operations and Corporate Development at Trovagene, Inc., a publicly traded molecular diagnostics company focused on liquid biopsy.

Previously, he served as Executive Vice President of Sequenom, Inc., where he managed global commercial operations of this molecular diagnostic company.

Mr. Terry has extensive international business experience including having served as Executive Vice President of European Operations for Lumenis Ltd.

He served at GE Healthcare's Marquette Medical division, where he held key executive positions in sales management, commercial operations and eBusiness, and was certified in Six Sigma.

Prior to GE, Mr. Terry served as Vice President of Global Sales for Aspect Medical Systems Inc., which was acquired in 2009 by Covidien (now Medtronic).

Additionally, he served as CEO of Ligand Dx, a startup in the neonatal diagnostic field.

Mr. Terry earned a BS in Economics and Business from the University of Wisconsin - Madison.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy